Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

By sjmartinez • May 7, 2025

Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan D, Lo Re V 3rd. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes. Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70154. doi: 10.1002/pds.70154. PMID: 40328444.

Tags: Cholangiocarcinoma, Infectious Diseases, liver cancer, Outcomes, Publications, validation studies, Veterans Administration

Using generative artificial intelligence to identify central line-associated bloodstream infections

Morgan DJ, AlShanqeeti S, Coffey KC, Baghdadi JD, Goodman KE, Holman JL, Pineles L, Goedken CC, Firestone C, Branch-Elliman W; VA AI CLABSI study group.[...]

Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica

Salih H, Samadzadeh S, Bereuter C, Motamedi S, Chien C, Villoslada P, Stiebel-Kalish H, Asgari N, Mao-Draayer Y, Ringelstein M, Havla J, Peixoto MAL, Kim[...]

Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis

GBD 2021 Global Sepsis Collaborators. Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis. Lancet Glob Health. 2025 Dec;13(12):e2013-e2026. doi: 10.1016/S2214-109X(25)00356-0. Epub[...]